These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9209586

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K.
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [Abstract] [Full Text] [Related]

  • 23. Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose.
    Huang SC, Phelps ME, Hoffman EJ, Kuhl DE.
    J Cereb Blood Flow Metab; 1981 Mar; 1(4):391-401. PubMed ID: 6976976
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The effect of naloxone on cerebral blood flow and glucose metabolism in patients with complex partial seizures.
    Theodore WH, Leiderman D, Gaillard W, Khan I, Reeves P, Lloyd-Hontz K.
    Epilepsy Res; 1993 Sep; 16(1):51-4. PubMed ID: 8243439
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synthesis of 2-[18F]fluoro-2-deoxy-L-glucose and positron emission tomography studies in monkeys.
    Meng J, Elmaleh DR, Jyawook S, Weiss S, Alpert NM, Babich JW, Tompkins RG, Fischman AJ.
    Nucl Med Biol; 1994 May; 21(4):633-40. PubMed ID: 9234321
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of regional blood-brain transport kinetics between glucose and fluorodeoxyglucose.
    Lear JL, Ackerman RF.
    J Nucl Med; 1992 Oct; 33(10):1819-24. PubMed ID: 1403150
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.
    Osman S, Danpure HJ.
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):183-90. PubMed ID: 1601671
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Transport of D-glucose and 2-fluorodeoxyglucose across the blood-brain barrier in humans.
    Hasselbalch SG, Knudsen GM, Holm S, Hageman LP, Capaldo B, Paulson OB.
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):659-66. PubMed ID: 8964806
    [Abstract] [Full Text] [Related]

  • 37. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J, Itoh M, Matsuzawa T.
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P, Dive D, Salmon E, von Frenckel R, Franck G.
    Eur J Nucl Med; 1990 Oct; 16(4-6):267-73. PubMed ID: 2351175
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.